HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by …

SG Priori, AA Wilde, M Horie, Y Cho, ER Behr, C Berul… - Heart rhythm, 2013 - Elsevier
SG Priori, AA Wilde, M Horie, Y Cho, ER Behr, C Berul, N Blom, J Brugada, CE Chiang…
Heart rhythm, 2013Elsevier
This international consensus statement is the collaborative effort of three medical societies
representing electrophysiology in North America, Europe and Asian-Pacific area: the Heart
Rhythm Society (HRS), the European Heart Rhythm Association (EHRA) and the Asia
Pacific Heart Rhythm Society. The objective of the consensus document is to provide clinical
guidance for diagnosis, risk stratification and management of patients affected by inherited
primary arrhythmia syndromes. It summarizes the opinion of the international writing group …
This international consensus statement is the collaborative effort of three medical societies representing electrophysiology in North America, Europe and Asian-Pacific area: the Heart Rhythm Society (HRS), the European Heart Rhythm Association (EHRA) and the Asia Pacific Heart Rhythm Society. The objective of the consensus document is to provide clinical guidance for diagnosis, risk stratification and management of patients affected by inherited primary arrhythmia syndromes. It summarizes the opinion of the international writing group members based on their own experience and on a general review of the literature with respect to the clinical data on patients affected by channelopathies.
This document does not address the indications of genetic testing in patients affected by inherited arrhythmias and their family members. Diagnostic, prognostic, and therapeutic implications of the results of genetic testing also are not included in this document because this topic has been covered by a recent publication 1 coauthored by some of the contributors of this consensus document, and it remains the reference text on this topic. Guidance for the evaluation of patients with idiopathic ventricular fibrillation, sudden arrhythmic death syndrome and sudden unexplained death in infancy, which includes genetic testing, are provided as these topics were not covered in the previous consensus statement.
Elsevier